September 2026Is selling a patent an investing activity? Yes. The cash you receive when you sell a patent goes in the investing section of the statement of cash flows, under both IFRS and US GAAP. That is the one-word answer every homework site gives you. What they skip is the part that actually costs marks, and occasionally costs a finance team an audit adjustment: where the gain on the sale goes, and the cases where patent cash is not investing at all. We sell and broker patents for a living at EX-IX, so we see both sides of these deals. Here is the full answer, tied to the paragraphs of the standards themselves. ## The short answer Under IFRS, IAS 7 paragraph 16(b) lists "cash receipts from sales of property, plant and equipment, intangibles and other long-term assets" as an example of investing cash flows. A patent is an intangible. Done. Under US GAAP, ASC 230 classifies the acquisition and disposal of "property, plant, and equipment and other productive assets used in the production of goods or services" as investing, as PwC's guide to ASC 230 summarises. A patent your company uses to protect its products is a productive asset. Same answer. So the line on the statement reads something like "Proceeds from sale of patent", as a positive number, inside cash flows from investing activities. ## Why a patent sale lands in investing IAS 7 defines investing activities as "the acquisition and disposal of long-term assets and other investments not included in cash equivalents." The logic is simple. Investing cash flows show what a company spends on resources meant to generate future income, and what it recovers when it lets them go. A patent fits that exactly. You do not buy or file one to resell it next week; you hold it for years to protect a product line or earn licence income. Accounting for Management groups patents with copyrights, trademarks and goodwill as intangible fixed assets and treats their purchase and sale as investing for that reason. If you want proof that the IFRS bodies read paragraph 16 this literally, look at football. When clubs asked how to present transfer fees received for players, the IFRS Interpretations Committee answered that IAS 7 lists cash receipts from sales of intangibles as investing, so those receipts go in investing activities. A player registration and a patent are both intangibles. The reasoning transfers directly. ## Where the gain goes: the indirect-method trap This is where exam answers go wrong. Suppose a company sells a patent. The numbers below are illustrative only, round figures chosen to show the mechanics: - Carrying amount of the patent on the balance sheet: 60,000
We use essential cookies to operate this website and, with your consent, optional cookies to understand site usage. You can accept or decline non-essential cookies at any time. See our Impressum for our contact and legal details.